Congenital heart disease in pregnancy;Übersichtsarbeit: Mutterschaft mit angeborenem Herzfehler

Deutsches Arzteblatt

Volumn 105, Issue 19, 2008, Pages 347-354

  Uebing, Anselm ^a,c   Gatzoulis, Michael A ^b   Von Kaisenberg, Constantin ^c   Kramer, Hans Heiner ^a   Strauss, Alexander ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Congenital heart disease; Maternity; Multidisciplinary care

Indexed keywords

ADAPTATION; ANTICOAGULATION; CARDIOVASCULAR SYSTEM; CHROMOSOME 22Q; CONGENITAL HEART DISEASE; FEMALE; HEART SURGERY; HUMAN; OBSTETRIC CARE; PATIENT COUNSELING; PREGNANCY; PREGNANT WOMAN; PUERPERIUM; REVIEW; THROMBOEMBOLISM;

EID: 45149123763     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2008.0347     Document Type: Review

References (25)

1. Nieminen HP, Jokinen EV, Sairanen HI: Late results of pediatric cardiac surgery in Finland: a population-based study with 96% follow-up. Circulation 2001;104: 570-5.
2. Thorne S, Deanfield J: Long-term outlook in treated congenital heart disease. Arch Dis Child 1996; 75: 6-8.
3. Kaemmerer H, Hess J: Adult patients with congenital heart abnormalities: present and future. Dtsch Med Wochenschr 2005; 130: 97-101.
4. Lewis G, Drife JO: Why mothers die 2000-2002 - the sixth report of confidential enquiries into maternal deaths in the United Kingdom. London: RCOG Press 2004.
5. Task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003; 24: 761-81.
6. Uebing A, Steer PJ, Yentis SM, Gatzoulis MA: Pregnancy and congenital heart disease. BMJ 2006; 332: 401-6.
7. Siu SC, Sermer M, Colman JM et al.: Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104: 515-21.
8. Siu SC, Sermer M, Harrison DA et al.: Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997; 96: 2789-94.
9. Drenthen W, Pieper PG, Roos-Hesselink JW et al.: Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49: 2303-11.
10. Siu SC, Colman JM, Sorensen S et al.: Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002; 105: 2179-84.
11. Nora JJ: From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol 1994; 23: 1468-71.
12. Steer PJ, Gatzoulis MA, Baker P: Consensus views arising from the 51st study group: heart disease and pregnancy. In: Steer PJ, Gatzoulis MA, Baker P, (eds.): heart disease and pregnancy. London: Royal College of Obstetricians and Gynaecologists Press 2006; 327-32.
13. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH: Using fetal nuchal translucency to screen for major congenital cardiac defects at 10 to 14 weeks of gestation: population based cohort study. BMJ 1999; 318: 81-5.
14. Hess J, Bauer U, de Haan F et al.: Empfehlungen für Erwachsenen- und Kinderkardiologen zum Erwerb der Zusatz-Qualifikation "Erwachsene mit angeborenen Herzfehlern" (EMAH). Clin Res Cardiol 2007; 2(Suppl 1): 19-26.
15. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 2004; 104: 647-51.
16. Leyendecker JR, Gorengaut V, Brown JJ: MR-imaging of maternal diseases of the abdomen and pelvis during pregnancy and the immediate postpartum period. Radiographics 2004; 24: 1301-16.
17. Schaefer C, Weber-Schöndorfer C: Medikamentöse Therapie in der Schwangerschaft. Dtsch Arztebl 2005; 102(37): A 2480-9.
18. Coon PD, Rychik J, Novello RT, Ro PS, Gaynor JW, Spray TL: Thrombus formation after the fontan operation. Ann Thorac Surg 2001; 71: 1990-4.
19. Bates SM, Greer IA, Hirsh J, Ginsberg JS: Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 Suppl): 627-44.
20. Immer FF, Bansi AG, Immer-Bansi AS et al.: Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann Thorac Surg 2003; 76: 309-14.
21. Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ: Pregnancy outcomes in women with congenital heart disease. Circulation 2006; 113: 517-24.
22. Chan WS, Anand S, Ginsberg JS: Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000; 160: 191-6.
23. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M: Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999; 33: 1637-41.
24. Oran B, Lee-Parritz A, Ansell J: Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 2004; 92: 747-51.
25. Cappelleri JC, Fiore LD, Brophy MT, Deykin D, Lau J: Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve-replacement: a metaanalysis. Am Heart J 1995; 130: 547-52.